29 / 112
27
WFSBP 2015
Monday, 15 June 2015
|
Scientific Programme
T16: G
enetics
S-12
Symposium
15:00–16:30
Mitropoulos Hall
Epigenetic acquisitions in mood disorders: Implication
for pathophysiology and treatment
Chair:
Carlo Altamura, Italy
S-12-001
Biological targets for epigenetic modulations in psychiatric
disorders
Nicolas Ramoz, France
S-12-002
Epigenetic regulation of BDNF gene in bipolar vs. unipolar
depressive disorders
Bernardo Dell´Osso, Italy
S-12-003
Epigenetic mechanisms and endocannabinoid signaling:
A putative treatment target for psychiatric disorders?
Mauro Maccarrone, Italy
T44: S
timulation
M
ethods
(ECT, TMS, VNS, DBS)
S-13
Symposium
15:00–16:30
MC 3 Room
Identifying the biological targets of treatment response
to neuromodulation in resistant psychiatric disorders
Chair:
Zafiris Daskalakis, Canada
Co-Chair: Aristotle Voineskos, Canada
S-13-001
Neurophysiological and symptomatic changes induced by
magnetic seizure therapy in depression
Zafiris Daskalakis, Canada
S-13-002
Cognitive, structural and connectivity changes from re-
petitive magnetic stimulation to the prefrontal cortex in
schizophrenia
Aristotle Voineskos, Canada
Z. J.Daskalakis, D. Blumberger, N. Neufeld, C. Hawco, T. Rajji
S-13-003
ECT-induced changes in functional connectivity in treatment
resistant depression
Georgios Petrides, USA
M. Argyelan, S. Kaliora
S-13-004
Neurobiological predictors of response to dorsolateral pre-
frontal cortex repititive transcranial magnetic stimulation
in depression
Daniel Blumberger, Canada
T20: M
olecular
N
eurobiology
S-14
Symposium
15:00–16:30
MC 2 Room
Neuron-Glia interactions and neuropsychiatric disease:
Implications for novel therapeutics
Chair:
Thomas Sedlak, USA
Co-Chair: Jean-Pierre Mothet, France
S-14-001
D-serine and glycine in gliotransmission: Synaptic and
extra-synaptic targets
Jean-Pierre Mothet, France
M. Le Bail, S. Sacchi, l. Pollegioni, J.-M. Billard
S-14-002
Neuron-astrocyte interactions–a critical juncture where
gene-environment interactions increase risk of psychiatric
disease
Mikhail Pletnikov, USA
S-14-003
Relationship between inflammatory cytokines, oxidative
stress and astrogliosis markers and prefrontal grey matter
volume in schizophrenia subgroups
Vibeke Catts, Australia
Y. Zhang, S. Fillman, J. Wong, S. Fung, C. Shannon Weickert
S-14-004
Interplay of neurons and glia for glutamate and glutathione
cycling – new avenues to target excitatory neurotransmis-
sion abnormalities in neuropsychiatric disorders
Thomas Sedlak, USA
T8: C
ognitive
N
euroscience
S-15
Symposium
15:00–16:30
Kokkali Room
Convergent approaches to impulsivity: The role of nor
adrenaline in ADHD and Parkinson‘s disease
Chair:
Ulrich Müller, United Kingdom
Co-Chair: Angie Kehagia, United Kingdom
S-15-001
The involvement of the noradrenergic system in impulsivity
associated with ADHD and Parkinson’s disease
Manfred Gerlach, Germany
S-15-002
PET imaging of the noradrenergic system in ADHD and
Parkinson’s disease
Rupert Lanzenberger, Austria
S-15-004
Noradrenergic modulation of impulsivity in Parkinson’s
disease
Angie Kehagia, United Kingdom